|
The New York University Pain Management Center is involved in developing
new treatments for pain relief and has various clinical research protocols
in place.
SNX-111.
This study uses a medication first
discovered in Australian Sea Snails (now made synthetically). This medication
is for people with severe pain who have been treated in many different
ways without relief. This medication is given by a tube placed into
the fluid around the spinal cord. If this medication relieves the pain
a permanent device (pump) is implanted under the skin to provide the
medication. Some of the pain syndromes that may be considered for this
study (but not limited to) are: cancer, chronic back pain, HIV/AIDS,
etc. In this study medical expenses such as the pump, drug and hospitalization
related to the trial will be provided free of charge.
The criteria to be considered for this study are:
- The patient is over 18 years old.
- The patient speaks and reads English.
- The patient is willing to comply with the protocol (fill out forms).
- The patient is suffering from chronic pain which is not relieved
by pain medication (narcotics, nonsteroidal anti-inflammatory, antidepressants,
anticonvulsants or other medications) or the patient is having intolerable
side effects.
- If the patient is currently receiving intrathecal pain medication
using a SynchroMed Infusion System, the patient must be weaned off
for three days and will receive pain medication in an alternative
method for three days prior to the study.
Reasons why you cannot be on the study are:
- The patient is pregnant or lactating.
- The patient has an infection in the body (not a local specific area).
- The patient has one of the following:
- congestive heart failure.
- sinus bradycardia with greater than first degree heart block.
- asthma.
- history of heart failure or neurocardiogenic syncope.
- The patient has a diagnosis or history of dementia and delirium.
- The patient has started an investigational drug regimen within 30
days.
- The patient has an implanted pump or implanted intrathecal catheters
other than SynchroMed system.
- The patient has a non-patent spinal canal.
|
